MARK JOSPEH YOCKEY
Allopathic & Osteopathic Physicians|Urology MERIDIAN, MS NPI 1326239203
Browse related groups: Allopathic & Osteopathic Physicians|Urology MS Astellas Pharma US Inc All categories
General Payments — all program years on this page
$5,277.56
- Category: General Payments
- Program years: PY2018–2024
- Record count: 142
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $199.14 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $131.14 | 7 |
| Education | $68.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $139.31 | 5 |
| Myriad Genetic Laboratories, Inc. | $24.87 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.25 | 1 |
| Sumitomo Pharma America, Inc. | $14.71 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086184888 | Bayer Healthcare Pharmaceuticals Inc. | $20.25 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139327022 | Astellas Pharma US Inc | $21.57 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139349258 | Astellas Pharma US Inc | $68.00 | 05/29/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1139391862 | Astellas Pharma US Inc | $15.04 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139417271 | Astellas Pharma US Inc | $16.79 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139436276 | Astellas Pharma US Inc | $17.91 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148938341 | Sumitomo Pharma America, Inc. | $14.71 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152543001 | Myriad Genetic Laboratories, Inc. | $24.87 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.